Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

N/ACompletedNCT01060787

Bausch & Lomb Incorporated98 enrolled

Overview

Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants

Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants on corneal endothelial cell density.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Inflammation Uveitis

Interventions

Fluocinolone Acetonide 0.59 mgPROCEDURE

At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density.

Fluocinolone Acetonide 2.1 mgPROCEDURE

At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density.

Eligibility

Sex: ALLMin age: 6 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Had the FA intravitreal implant (0.59 or 2.1 mg) in only one eye for at least one(1) year * Able and willing to follow instructions * Able and willing to provide informed consent Exclusion criteria: * Is monocular * Has current or relevant medical history that would interfere with their participation in this study, based on the judgment of the Investigator * Had bilateral FA intravitreal implants * Has a history of any severe/serious ocular pathology or medical condition that could result in the subject's inability to complete the study

Locations (1)

Ophthalmic Partners of Boston

Boston, Massachusetts, United States

Outcomes

Primary Outcomes

Corneal Endothelial Cell Density

Bilateral specular microscopy will be performed and endothelial cell density will be recorded.

Time frame: 1 Visit

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.